Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Roche Posts Higher Sales on Growth Across Pharma, Diagnostics Units
reported higher sales for the third quarter on growth in its pharmaceuticals and diagnostics units, as the drugmaker works to secure approval for its new breast-cancer and multiple-sclerosis pills. The Swiss group said Thursday that third-quarter…
Big pharma accused of 'free-riding on nature' as global fund attracts just $7,000
Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty. The Cali Fund set out…
Rigel Pharmaceuticals: Turning Big Pharma's Castoffs Into A Growth Engine (NASDAQ:RIGL)
Rigel Pharmaceuticals is evolving into a multi-product oncology platform, leveraging Big Pharma castoffs to drive growth beyond its ITP legacy. VEPPANU's U.S. launch targets a $1B ESR1-mutated breast cancer market, with early metrics excluded from…
3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
Healthcare isn't optional, which makes the pharmaceutical sector fairly resilient through the entire economic cycle. Royalty Pharma (RPRX +1.75%) has created a diversified portfolio of royalties on drugs that are approved for sale and on drugs that…
LSL PHARMA GROUP INC. TO PRESENT AT THE 'PLANET MICROCAP TORONTO 2026'
BOUCHERVILLE, QC, Oct. 22, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced it will be presenting at the Planet MicroCap Toronto 2026 powered by…
Second life for pharma's secret drug discovery data
A new and powerful Australian artificial intelligence model can comb through data from confidential pharmaceutical trials – both failed and successful – to help big pharma companies avoid wasting their resources on already…
How The NYT Hid Big Pharma PR Titan Jack Leslie In Plain Sight
New York Times reporter Sheryl Gay Stolberg wrote one of the most hilarious, misleading pieces I've seen in recent months, castigating the NIH for a new vaccine injury clinic based on a leaked statement by Jack Leslie, a senior advisor to the PR…
Big Pharma vs. Breakthrough Biotech: Which ETF Has More Upside for Investors?
The Invesco Pharmaceuticals ETF (PJP -0.51%) offers a lower-volatility approach to healthcare than the Invesco Biotechnology & Genome ETF (PBE +0.35%), which prioritizes high-growth but more volatile firms specializing in genomic research and…
Zuellig Pharma expands cold chain capacity in Korea
Global healthcare logistics provider now has one of the largest cold chain storage facilities in Korea Zuellig Pharma Korea said Thursday it had expanded its cold chain facilities at its hub in Anseong, Gyeonggi Province, as demand for refrigerated…
Bender Robert & Associates Purchases New Stake in Urogen Pharma $URGN
Bender Robert & Associates purchased a new position in Urogen Pharma (NASDAQ:URGN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 34,701 shares of the company's stock…
Foster Victor Wealth Advisors LLC Acquires 33,055 Shares of Royalty Pharma PLC $RPRX
Foster Victor Wealth Advisors LLC raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.
Tech Stocks Took a Hit-These 2 Pharma Stocks Are Near New Highs
While attention has focused on the brutal sell-off tearing through the technology sector and the AI trade, something notable has been happening in another corner of the market. The biotech and pharmaceutical sector has held its ground and…
Legend Biotech Stock: CARVYKTI Makes Billions, But The Profits Are Elusive (NASDAQ:LEGN)
CARVYKTI's quarterly sales reached $710 million, but Legend's high expenses have kept recurring profitability low. Q2 results show improving operating leverage, with collaboration revenue growing faster than associated costs. I rate LEGN a cautious…
NDTV Profit Reports Three Stock-Futures Calls From ICICI Securities' Jay Thakkar
NDTV Profit reported on Oct. 22 that Jay Thakkar, vice president and head of derivatives and quant research at ICICI Securities, outlined three Indian stock-futures positions for the session: two long positions and one short. The calls included…
Sensex plunges over 400 points
Indian equity markets ended in the red for the third consecutive session on Thursday, with the Sensex plunging over 400 points and the Nifty slipping below the 22,700 mark, as elevated crude oil prices and escalating geopolitical tensions weighed…
Receive a Daily briefing on Pharma Industry News
Get Started